Swarthmore Group Inc. Has $9.77 Million Holdings in Thermo Fisher Scientific Inc. (TMO)

Swarthmore Group Inc. boosted its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 24.1% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 51,450 shares of the medical research company’s stock after purchasing an additional 10,000 shares during the period. Thermo Fisher Scientific makes up approximately 2.1% of Swarthmore Group Inc.’s portfolio, making the stock its 11th biggest holding. Swarthmore Group Inc.’s holdings in Thermo Fisher Scientific were worth $9,769,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently made changes to their positions in TMO. Beach Investment Management LLC. grew its position in Thermo Fisher Scientific by 1,702.8% during the 2nd quarter. Beach Investment Management LLC. now owns 71,661 shares of the medical research company’s stock worth $12,503,000 after purchasing an additional 67,686 shares during the period. Wetherby Asset Management Inc. boosted its stake in shares of Thermo Fisher Scientific by 13.0% during the 2nd quarter. Wetherby Asset Management Inc. now owns 6,169 shares of the medical research company’s stock worth $1,076,000 after acquiring an additional 711 shares in the last quarter. Schwab Charles Investment Management Inc. boosted its stake in shares of Thermo Fisher Scientific by 9.6% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 1,537,059 shares of the medical research company’s stock worth $268,171,000 after acquiring an additional 135,068 shares in the last quarter. C WorldWide Group Holding A S boosted its stake in shares of Thermo Fisher Scientific by 11.4% during the 2nd quarter. C WorldWide Group Holding A S now owns 2,172,238 shares of the medical research company’s stock worth $378,990,000 after acquiring an additional 222,189 shares in the last quarter. Finally, Sound Shore Management Inc. CT boosted its stake in shares of Thermo Fisher Scientific by 2.9% during the 2nd quarter. Sound Shore Management Inc. CT now owns 1,101,543 shares of the medical research company’s stock worth $192,186,000 after acquiring an additional 31,496 shares in the last quarter. 86.25% of the stock is currently owned by institutional investors.

Several research firms have recently issued reports on TMO. Zacks Investment Research lowered shares of Thermo Fisher Scientific from a “hold” rating to a “sell” rating in a research note on Thursday, January 11th. Deutsche Bank set a $226.00 target price on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research note on Thursday, October 26th. BTIG Research began coverage on shares of Thermo Fisher Scientific in a research note on Friday, January 5th. They set a “buy” rating and a $230.00 target price on the stock. Leerink Swann increased their target price on shares of Thermo Fisher Scientific from $190.00 to $207.00 and gave the stock an “outperform” rating in a research note on Monday, October 9th. Finally, Evercore ISI began coverage on shares of Thermo Fisher Scientific in a research note on Wednesday, January 3rd. They set an “outperform” rating and a $220.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and fifteen have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $212.21.

Shares of Thermo Fisher Scientific Inc. (NYSE TMO) traded up $0.93 during trading on Thursday, reaching $212.41. 1,440,000 shares of the company were exchanged, compared to its average volume of 1,650,000. The stock has a market cap of $84,730.00, a price-to-earnings ratio of 36.06, a PEG ratio of 1.69 and a beta of 1.06. Thermo Fisher Scientific Inc. has a 1 year low of $140.00 and a 1 year high of $213.06. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.26 and a quick ratio of 0.81.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings results on Wednesday, October 25th. The medical research company reported $2.31 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.24 by $0.07. The firm had revenue of $5.12 billion for the quarter, compared to analyst estimates of $5.03 billion. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. Thermo Fisher Scientific’s quarterly revenue was up 13.9% compared to the same quarter last year. During the same period last year, the company posted $2.03 EPS. equities analysts anticipate that Thermo Fisher Scientific Inc. will post 9.36 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Monday, January 15th. Shareholders of record on Friday, December 15th were issued a $0.15 dividend. The ex-dividend date of this dividend was Thursday, December 14th. This represents a $0.60 dividend on an annualized basis and a yield of 0.28%. Thermo Fisher Scientific’s payout ratio is 10.19%.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 50,000 shares of the stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $191.74, for a total value of $9,587,000.00. Following the completion of the sale, the chief executive officer now owns 302,577 shares in the company, valued at approximately $58,016,113.98. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.49% of the stock is currently owned by corporate insiders.

TRADEMARK VIOLATION WARNING: This news story was reported by Week Herald and is the sole property of of Week Herald. If you are accessing this news story on another website, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The original version of this news story can be viewed at https://weekherald.com/2018/01/18/swarthmore-group-inc-has-9-77-million-holdings-in-thermo-fisher-scientific-inc-tmo.html.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply